Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1/2 13Phase 1 8Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 24Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 14Lymphoma, Mantle-Cell 9Lymphoma 6Lymphoma, B-Cell, Marginal Zone 5Recurrence 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 2Leukemia 2Hematologic Diseases 2Waldenstrom Macroglobulinemia 1Tumor Lysis Syndrome 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Leukemia, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Chromosome 17 deletion 1

Interventions

Dexamethasone 168Bortezomib 90Lenalidomide 85Thalidomide 44daratumumab 43pomalidomide 42Melphalan 39Cyclophosphamide 33carfilzomib 29Calcium Dobesilate 27Prednisone 19Doxorubicin 16elotuzumab 14Filgrastim 12ixazomib 11isatuximab 11Vincristine 10Peripheral Blood Stem Cell Transplantation 10belantamab mafodotin 9Granulocyte Colony-Stimulating Factor 9Zoledronic Acid 8selinexor 7dexamethasone acetate 7Epoetin Alfa 7Etoposide 6fludarabine 5Cisplatin 5Carmustine 5Radiotherapy 4Mycophenolic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Multiple Myeloma × Bendamustine Hydrochloride × Clear all
NCT05006469 2021-08-16

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Shengjing Hospital

Phase 3 Unknown
10 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡